Background/aims-Chemokines are small peptides which are potent activators a
nd chemoattractants for leucocyte subpopulations. Their action is mediated
by a family of seven transmembrane spanning G-protein coupled receptors. Th
e aims of this study were to examine the expression of the chemokine recept
ors CCR1, CCR3, CCR5, CXCR3, and CXCR4 in the conjunctiva of patients with
vernal keratoconjunctivitis (VKC) and to investigate the phenotype of infla
mmatory cells expressing these chemokine receptors.
Methods-Conjunctival biopsy specimens from 16 patients with active VKC, and
eight control subjects were studied by immunohistochemical techniques usin
g a panel of monoclonal antibodies directed against human CCR1, CCR3, CCR5,
CXCR3, and CXCR4. The phenotype of inflammatory cells expressing chemokine
receptors was examined by double immunohistochemistry.
Results-In the normal conjunctiva, few inflammatory cells expressed CXCR3 i
n five of eight specimens. There was no immunoreactivity for CCR1, CCR3, CC
R5, and CXCR4. In VKC specimens, membranous immunoreactivity for CXCR3 was
noted on inflammatory cells in all specimens. Compared with control specime
ns, VKC specimens showed significantly more inflammatory cells expressing C
XCR3 (54.3 (SD 34.3) v 3.3 (5.0); p<0.001). Few CCR1(+), CCP3(+), CCR5(+),
and CXCR4(+) inflammatory cells were observed in only three of 16 specimens
. Double immunohistochemistry revealed that all CXCR3 positive inflammatory
cells were CD3 positive T lymphocytes and that 61.7% (3.7%) of the infiltr
ating T lymphocytes were reactive for CXCR3.
Conclusions-CXCR3 is the predominant chemokine receptor and is expressed ab
undantly on T lymphocytes in the conjunctiva of patients with active VKC. T
hese data suggest a potential role for CXCR3 receptors in the regulation of
lymphocyte recruitment within conjunctiva of VKC patients. New therapeutic
strategies that block CXCR3 may inhibit T lymphocyte recruitment and suppr
ess adverse inflammatory reactions.